Clexza 100mg TAB (Venetoclax Tablet) 100MG

Clexza 100mg TAB contains venetoclax, a prescription medication used in certain blood cancers. It belongs to the BCL-2 inhibitor class and is taken orally. This 100mg strength tablet is supplied in packs of 30. Always follow healthcare provider guidance when using venetoclax.

Strength

100MG

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Azista Bhutan Healthcare Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venetoclax is prescribed for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It may also be used for acute myeloid leukemia in specific cases. This medication helps manage certain blood cancers by targeting cancer cells. Patients often ask, 'what is venetoclax used for' to understand its role in treatment.

Side Effects

Venetoclax works by helping the body’s immune system recognize and destroy cancer cells. Many patients notice improved blood counts over time with consistent use. Some experience mild gastrointestinal effects like nausea or diarrhea. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Store venetoclax at room temperature away from moisture and heat. Keep tablets in their original packaging until use to protect from light. Always handle with clean, dry hands to maintain tablet integrity. Avoid splitting or crushing tablets unless directed by a healthcare professional.

Avoid Interactions

Venetoclax can interact with other medications, including certain antibiotics and antifungals. Strong CYP3A inhibitors may increase venetoclax levels, requiring dose adjustments. Grapefruit products should be avoided due to potential interaction risks. Always inform your doctor about all medications you take.

Frequently Asked Questions

Venetoclax is used to treat certain types of blood cancers like chronic lymphocytic leukemia and small lymphocytic lymphoma.

Store venetoclax at room temperature in a dry place, away from direct light and moisture.

Do not split or crush venetoclax tablets unless instructed by your healthcare provider.

Yes, grapefruit and grapefruit juice may interact with venetoclax and should be avoided.

Contact your healthcare provider for guidance if you miss a dose; do not take extra tablets to compensate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.